TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Incremental area under the curve of blood glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: THC-COOH levels in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Irritation of test products
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Blood Oxygenation Level-dependent (BOLD) Changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Postprandial serum total triglycerides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Positive blood microbial DNA count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Area under the concentration-time curve from dosing to last measurable concentration (AUClast)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve from dosing to infinity (AUCinf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with confirmed composite endpoint
Endpoint domain: Mortality/survival
Primary endpoint: Change in erythropoietin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Long-term change of renal function (eGFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Percent Of Patheroma Volume (PAV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Craving - self report
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive and Behavioral Control - self report impulsivity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Regulation of Affect/Arousal - negative affect self-report
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Success rate of simple aspiration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: 1 Week Delayed Recall of Emotional Story Items
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: 1 Week Delayed Recall Logical Memory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Length of Respiratory Support
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of Patients With Specific Toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Best Response to Combination Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetic parameters (AUC, Cmax, Tmax, T1/2, fe, CL/F)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion of procedure by SSRC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in Berlin Bimanual Task Assessment (BEBITA) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective Ratings of Lens Handling for Insertion
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Subjective Ratings of Lens Handling for Removal
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ankle-Brachial Index (ABI-C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Flow-mediated Dilation (FMD-C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Carotid Intima-media Thickness (CIMT-F)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: N-terminal pro-BNP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change of score of the Activities Scale for Kids - performance version
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Mean Pain (NRPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Binary In-segment Restenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Hemodynamic Compromise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Post-COVID symptoms onset at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: T-wave elevation in the ECG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Morisky Medication Adherence Scale (MMAS) Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: arrhythmia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in Putrescine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Venous responsiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: ED50 and ED95 of intrathecal hyperbaric bupivacaine with fentanyl
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Efficiency of gas exchange (Ve/VO2 and Ve/VCO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Progression Free-Survival
Endpoint domain: Mortality/survival
Primary endpoint: Changes in Numerical Rating Score (NRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change in Volume of Reference Leg
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS score on wound site and posterior neck
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Baseline-adjusted pre-dose FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Functional index for hand osteoarthritis (FIHOA)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Patient specific function scale (PSFS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in markers of increased cardiovascular risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percent Change on the Action Myoclonus Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Progression-Free Survival (PFS) at 180 Days
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of any-grade paclitaxel hypersensitivity reactions (HSR) in the first cycle
Endpoint domain: Adverse events/effects
Primary endpoint: Physicians' questionnaire score
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Patients' questionnaire score
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Expression of long non coding RNA HOTAIR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in infection frequency
Endpoint domain: Adverse events/effects
Primary endpoint: Completion of required assessment visits
Endpoint domain: Mortality/survival
Primary endpoint: Type and number of organisms found in culture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Proportion of patients with grade 2 or 3 cardiac uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Safety of CART cells infusion
Endpoint domain: Adverse events/effects
Primary endpoint: Establishing the diagnosis of multiple sclerosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Horizontal bone gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Clinical Symptoms of Autism Spectrum Disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dosage of 5 proteins
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of inadequately managed episodes of breakthrough pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: unstimulated whole saliva flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical stabilization through standard clinical dialysis labs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of patient symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of patients with an immune response to the peptides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Improvement in oxygen saturation (SpO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean 2 hour postprandial plasma glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of residents accepting participation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of residents completing the program
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time to Virologic Failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: 24-hour intragastric pH at Day 5
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: healing status of moderate to severe erosive esophagitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Bone Mineral Strength Index (BMSi)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in Patient-Reported Symptoms of Varicose Veins (VVSymQ Score)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Lid and Lid Margin Erythema, Change From Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Intraocular Pressure, Change From Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Visual Acuity Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the HERO Wellness Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Cognitive and Physical Functioning Questionnaire (CPFQ)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Near infrared spectroscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: High performance liquid chromatography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline to Day 10 in 24-hour Mean Ambulatory Systolic Blood Pressure (SBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participants Who Discontinued the Study Medication Due to an AE
Endpoint domain: Adverse events/effects
Primary endpoint: Recurrence of cervical uterine cancer
Endpoint domain: Mortality/survival
Primary endpoint: Spherical equivalent in diopters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of invasive life support
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: voice symptom
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global score of the MAUQ questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: change in vital signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Orthostatic Hypotension Questionnaire Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Difficulty level
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Proportion of Veterans selecting comfort-oriented plans of care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: composite of fatal and non-fatal stroke and other cardiovascular events
Endpoint domain: Mortality/survival
Primary endpoint: Alcohol Consumption as Measured by Phosphatidylethanol (PEth) in Blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alcohol Consumption as Measured by Heavy Drinking Days (HDD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Period to Return to Normal Creatinine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Complications of Each Drainage Method
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Hypoxic Burden (HB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in HOMA ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Discrimination between healthy liver tissue and colorectal liver metastases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Presence of Blood Inflammatory Biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Presence of Skin Inflammatory Biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Participants Who Experienced Psoriasis Relapse
Endpoint domain: Adverse events/effects
Primary endpoint: Gut microbiota function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate and spectrum of all toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline in blood lab values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change from baseline in adverse events measures
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline in physical exam measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Patients for Whom the Intended Treatment Was Feasible
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of Patients With Change in Child Pugh Score >= 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Median Time to Local Progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Reduction in number of inflammatory lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Time to Full Expansion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in serum GLP-1 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Area under the S-warfarin concentration-time curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the R-warfarin concentration-time curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the lisinopril concentration-time curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AIMS Dyskinesia Total Score Change From Baseline at Week 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Subjects with drug-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Oxygen consumption during maximal tolerated exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Tibial Speed of Sound
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in Serum biomarkers of Bone-specific phosphatase markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Serum biomarkers of osteocalcin markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Serum biomarkers of Beta-cross Laps
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Urine biomarkers of N-telopeptides from collagen bonds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean change from baseline ETDRS BCVA letters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Mid-Face Volume Deficit Scale (MFVDS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Standardized index of knowledge about sexual and reproductive health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of patients with abnormal changes in laboratory tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of need for medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Help-Seeking Behavior
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: oxycodone consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Combined end point of all cause mortality
Endpoint domain: Mortality/survival
Primary endpoint: Rebleeding rate after EMR procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Aided AAC Utterance Length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Provocative concentration of AMP or Allergen causing a 20% drop in Peak Nasal Inspiratory Flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Acute Toxicity Profile
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of complete hematologic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Plasma Nitric Oxide Level Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of catheter passes or attempts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Accuracy of catheter tip compared to foramen of Monro
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change of fecal microbiota composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Knee Injury and Osteoarthritis Outcome Score (KOOS) change
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: International Knee Documentation Committee Subjective Knee Evaluation Form (IKDC Score) change
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change over time in Pain Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Opioids Administered
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: EVs levels in early breast cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EVs levels in metastatic breast cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of acute rejection confirmed by biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Gene expression changes at metastatic sites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported distress levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: composite adverse event rate
Endpoint domain: Adverse events/effects
Primary endpoint: Change in tinnitus distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cytokine concentrations in BAL fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in lipoprotein metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in total inflammatory lesion count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: rate of diabetic foot ulcer recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Efficacy of irbesartan regimens
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of subjects experiencing a dose-limiting toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Tissue Distribution of F-18 BF4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma concentration of metformin extended release
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants with pulmonary arterial hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Gastrointestinal Symptom Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: New infections
Endpoint domain: Adverse events/effects
Primary endpoint: Performance and errors of participants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-day post-discharge outcomes
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Pain-free IV insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Relapse-free Survival at 18 Months
Endpoint domain: Mortality/survival
Primary endpoint: Change in Quality of Life - 1
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Central and Peripheral Arterial Stiffness (AS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Event-free Survival (EFS) in Standard Risk APL Patients
Endpoint domain: Mortality/survival
Primary endpoint: Event-free Survival (EFS) in High Risk APL Patients
Endpoint domain: Mortality/survival
Primary endpoint: unfavorable outcome in breast cancer
Endpoint domain: Mortality/survival
Primary endpoint: Change in SP Index scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of solicited adverse events (AEs)
Endpoint domain: Adverse events/effects